Recently, the results of the pivotal Phase III clinical trial (EECOH-1) of ecnoglutide injection, developed by Sciwind ...

The Global Plexiform Neurofibroma Market centers on the treatment of plexiform neurofibromas, benign nerve sheath tumors linked to Neurofibromatosis Type 1 (NF1). These tumors cause significant ...

OverviewThe global virtual clinical trials market is projected to expand at a steady pace, with an expected growth rate of around 6% over the next five years. This momentum is largely supported by the ...

ABU DHABI, 28th January, 2026 (WAM) -- The World Organisation for Animal Health (WOAH) has endorsed a scientific twinning programme between the Abu Dhabi Agriculture and Food Safety Authority's ...

LSL PHARMA GROUP INC. (The "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it has secured certification from the U.S. Food and Drug ...

The global immunoassay market is projected to expand at a compound annual growth rate (CAGR) of approximately 6–7% over the ...

An integrated suite of licensed, doctor-led services designed to support everyday health, recovery, and longevity ...

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers.

A fundamental transformation in the way health data is managed is needed if Australia is to meet the health challenges of an ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition globally, with its management spanning ...

The Washington Blade this month welcomed Sam Epner as its spring intern. Sam is a freshman at American University and is studying journalism and creative writing. Sam is originally from California. “D ...

Global Healthcare automation Market size is expected to be worth around USD 119.5 Billion by 2033 from USD 49.5 Billion in ...